SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - North AmericaEU edition

Top Headlines

The top picks from the education sessions at the Healthy & Natural Show

The inaugural Healthy & Natural Show kicks off on Thursday, May 5 with a top quality education program. In this special gallery we trawl through the program and give you our top picks for the event at Chicago’s Navy Pier.

The top picks from the education sessions at the Healthy & Natural Show

GNC announces strategic, financial review to increase shareholder value

Dietary supplement heavyweight GNC Holdings has started a review of a wide range of strategic and financial alternatives to increase shareholder value.

Marketer writes down remaining BluScience inventory, pivots toward ChromaDex's PurEnergy ingredient

Canadian supplement company NeutriSci has now dropped all sales of ChromaDex’s pTeroPure ingredient in favor of an energy product line based upon its PurEnergy ingredient, which is a pTeroPure/caffeine co crystal. 

Founding member AstaReal withdraws from NAXA

Founding member AstaReal has withdrawn from the Natural Algae Astaxanthin Association, while at the same time the association announced a new member, Chinese company Yunnan Alphy Biotech Company, Ltd.

News in brief

Nutrition 21 announces new president

Purchase, NY-based Nutrition 21, LLC, has announced the appointment of Joe Weiss as its new president.

CBD firm CV Sciences posts sales gain, still struggles with net losses

One of the first companies to jump into the current CBD game, CV Sciences, Inc., reported $11.5 million in sales for 2015 as it continues to struggle toward profitability.

3 years, 3 countries, 222 children: Big gut data tracks impact of hygiene on microbiome

Gut microbiome development in the early stages of life may explain the rise in autoimmune diseases such as diabetes and multiple sclerosis, a study reports.  

COMMUNITY INSIGHTS

By InterHealth Nutraceuticals, Inc.

Content Provided by InterHealth Nutraceuticals, Inc.

How IRI scan data show UC-II can drive joint health supplement growth

Joint relief has traditionally been a profitability powerhouse, but recently the sector has slumped. Now, data suggest its salvation may lie in an ingredient: UC-II.